Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.150 | 3.150 | 0.000 |
Stocks | 96.730 | 96.730 | 0.000 |
Other | 0.120 | 0.120 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.928 | 16.193 |
Price to Book | 3.516 | 2.734 |
Price to Sales | 2.801 | 2.094 |
Price to Cash Flow | 14.365 | 10.492 |
Dividend Yield | 1.624 | 2.823 |
5 Years Earnings Growth | 14.148 | 12.469 |
Name | Net % | Category Average |
---|---|---|
Technology | 22.510 | 20.386 |
Healthcare | 16.550 | 12.779 |
Consumer Cyclical | 12.600 | 12.444 |
Financial Services | 12.560 | 19.715 |
Industrials | 11.900 | 13.873 |
Communication Services | 11.130 | 9.316 |
Basic Materials | 4.320 | 8.992 |
Consumer Defensive | 4.300 | 8.333 |
Energy | 2.700 | 8.361 |
Utilities | 0.980 | 5.574 |
Real Estate | 0.450 | 4.364 |
Number of long holdings: 255
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Meta Platforms | US30303M1027 | 3.78 | 700.63 | +1.66% | |
Microsoft | US5949181045 | 3.26 | 414.07 | -0.24% | |
Taiwan Semicon | TW0002330008 | 3.23 | 1,070.00 | -5.73% | |
Broadcom | US11135F1012 | 2.79 | 218.17 | -1.40% | |
Novo Nordisk B | DK0062498333 | 2.50 | 599.7 | -1.25% | |
NVIDIA | US67066G1040 | 2.24 | 117.93 | -1.79% | |
Tesla | US88160R1014 | 1.96 | 384.18 | -5.05% | |
AstraZeneca | GB0009895292 | 1.58 | 11,276.0 | -0.60% | |
Eli Lilly | US5324571083 | 1.51 | 812.02 | +0.12% | |
Netflix | US64110L1061 | 1.41 | 984.25 | +0.77% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CapGroup NewPerspective lux Cad AUD | 16.62B | 24.27 | 7.39 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review